吡柔比星联合顺铂在Ⅲ期非小细胞肺癌新辅助化疗的应用(附32例报告)
摘要
目的探讨以吡柔比星为主的联合化疗在Ⅲ期非小细胞肺癌新辅助化疗的临床应用。方法32例患者于术前应用吡柔比星及顺铂化疗方案联合化疗2个周期,观察其疗效及毒副反应。结果全组总有效率为50%,毒副反应以骨髓抑制为主。结论以吡柔比星及顺铂为主联合化疗用于III期非小细胞肺癌的新辅助化疗,疗效满意且毒副反应轻,有利于下一步手术治疗。
出处
《中国医师杂志》
CAS
2006年第3期422-423,共2页
Journal of Chinese Physician
参考文献1
-
1周清华,刘伦旭,李潞,车国卫,杨俊杰,赵雍凡,陈军,王允,秦建军,侯梅,宫友陵,卢武胜,李志平.术前新辅助化疗加外科手术治疗Ⅲ期非小细胞肺癌的随机对照临床试验[J].中国肺癌杂志,2001,4(4):251-256. 被引量:102
二级参考文献16
-
1Eberhardt W, Wilke H, Stamatis G, et al. Preoperative chemotherapy followed byconcurrent chemoradiation therapy based on hyperfractionated accelerated radiotherapy anddefinitive surgery in locally advanced non-small cell lung cancer: mature results of aphase Ⅱ trial. J Clin Oncol,1998,16(3)∶622-634.
-
2Fleck J, Camargo J, Godoy D, et al. Chemoradiation therapy alone versuschemotherapy alone as a neoadjuvant treatment for stage Ⅲ non-small cell lung cancer.Proc Am Soc Clin Oncol,1993,12(2)∶333.
-
3Gandara DR, Leigh B, Vallieres E, et al. Preoperative chemotherapy in stage Ⅲnon-small cell lung cancer: Long-term outcome. Lung Cancer,1999,26(1)∶3-6.
-
4Rosell R, Gomez CJ, Camps C, et al. Preresectional chemotherapy in stage Ⅲnon-small cell lung cancer: a 7-year assessment of a randomized controlled trial. LungCancer,1999,47(1)∶7-14.
-
5Roth JA, Atkinson EN, Fossella F, et al. Long-term follow-up of patients enrolleda randomized trial comparing perioperative chemotherapy and surgery with surgery alone inresectable stage ⅢA non-small cell lung cancer. Lung Cancer,1998,21(1)∶1-6.
-
6Albain KS, Pass HI. Induction therapy before surgery for non-small cell lungcancer. Lung Cancer,2000,29(Suppl 2)∶168-171.
-
7Mattson K, Velde T, Krotta K, et al. Early results of an international phase Ⅲstudy evaluating Toxotere as neoadjuvant therapy for radically treatable stage Ⅲ NSCLC.Lung Cancer,2000,29(Suppl 1)∶90.
-
8Abolhoda A, Martin J, Ginsberg RJ, et al. Morbidity and modality for pulmonaryresections in lung cancer after induction treatment. Lung Cancer,2000,29(Suppl 1)∶89.
-
9Takamori S, Rikimaru T, Hayashi A, et al. A preoperative alternating chemotherapyand radiotherapy program for patients with stage ⅢA(N2) non-small cell lung cancer. LungCancer,2000,29(1)∶49-56.
-
10Strupp J, Johnson DH, Greco FA, etal. Combined treatment of small cell bronchopulmonary cancer. Results of a retrospectivestudy of 59 patients. Rev Pneumol Clin,1984,40(5)∶327-331.
共引文献101
-
1齐晋,李兆元.CEA及CA125对中晚期肺腺癌化疗疗效的预测及护理措施[J].医学信息(医学与计算机应用),2014,0(22):129-130.
-
2周清华.N2非小细胞肺癌外科治疗进展[J].中国肺癌杂志,2008,11(5):611-614. 被引量:9
-
3张金星.基层医院老年肺癌的循征治疗[J].兵团医学,2005(3):21-24.
-
4彭忠民,陈景寒,王潍博,王晓航.新辅助化疗对Ⅲ期非小细胞肺癌围手术期的影响[J].肿瘤防治杂志,2004,11(6):632-634. 被引量:2
-
5务森,陈宇航,马智勇,夏庆欣,陈明耀.Ⅲa期非小细胞肺癌术前应用辅助化疗27例疗效观察[J].肿瘤防治研究,2004,31(10):649-649.
-
6周清华.局部晚期非小细胞肺癌治疗的争议与共识[J].医师进修杂志(外科版),2004,27(10):10-14. 被引量:6
-
7周清华.局部晚期非小细胞肺癌治疗的争议与共识[J].肿瘤防治杂志,2004,11(7):749-752. 被引量:3
-
8李强,彭林,何金涛,朱江,方强,韩泳涛,宋煜宏,陈利华.外科治疗局部晚期非小细胞肺癌的疗效分析[J].四川肿瘤防治,2003,16(1):27-29. 被引量:1
-
9王龙垣,巫志华,刘小华,刘可期.术前新辅助化疗加手术治疗非小细胞肺癌的临床观察[J].临床肺科杂志,2005,10(3):289-290. 被引量:2
-
10李晓明,黄国胜,杨军,郭彦伟,杨金华.新辅助化疗在ⅢA期非小细胞肺癌外科手术治疗中的应用价值[J].河南外科学杂志,2005,11(3):32-33. 被引量:5
-
1郝勤岭.年龄、性别、剂量对顺铂化疗方案所致消化道反应差异之分析[J].河南医药信息,2000,8(7):52-53.
-
2邓周峰,邢怡.贝伐单抗联合培美曲塞加顺铂化疗方案对非小细胞肺癌患者生存率的影响[J].实用癌症杂志,2017,32(3):469-472. 被引量:12
-
3尤明科,张巧云,魏连军.不同途径应用含顺铂化疗方案副作用比较观察[J].蚌埠医学院学报,1997,22(6):400-401.
-
4杨毅,吴霞.紫杉醇联合顺铂治疗晚期食道癌的临床效果探究[J].中国农村卫生,2015,7(4X):29-30. 被引量:4
-
5方安平,王建屏,何艳芬,李琳慧.长春瑞滨联合顺铂治疗晚期非小细胞肺癌疗效观察[J].当代医学,2016,22(14):146-147. 被引量:3
-
6怀淑君,冯三吉,孙雪梅.热化疗治疗晚期非小细胞肺癌[J].吉林大学学报(医学版),2002,28(5):548-549. 被引量:7
-
7庆桂.硝酸甘油可改善肺癌的化疗效果[J].中国医疗前沿,2006,0(S1):83-83.
-
8林峰,唐晓春,蔡讯,姚阳.甲强龙对含顺铂化疗方案所致恶心、呕吐的疗效观察[J].安徽卫生职业技术学院学报,2005,4(1):23-24. 被引量:1
-
9冯献明,付方现,刘俊叶,韩文清,李永峰.艾迪注射液联合5-氟尿嘧啶加顺铂化疗方案治疗中晚期肝癌[J].新乡医学院学报,2010,27(3):273-275. 被引量:9
-
10孙蕾,顾亮.艾迪联合吉西他滨与顺铂化疗方案治疗晚期非小细胞肺癌的回顾性研究[J].中国临床药理学杂志,2014,30(5):405-407. 被引量:24